Abstract
A 41-year-old man was referred to our hospital for the evaluation of hypergammaglobulinemia (IgG 2898 mg/dL and IgA 587 mg/dL), inflammation (CRP 6.7 mg/dL and serum interleukin-6 (IL-6) 15.1 ng/L), and anemia (Hb 10.9 mg/dL). Castleman’s disease (CD) was diagnosed by axillary lymph node biopsy. Five months later, painful purpura (multiple palpable 5 mm lesions) developed on his legs, gradually spreading to the upper limbs, thighs, and trunk, accompanied by arthralgia of the wrists, ankles, and knees. Skin biopsy revealed leukocytoclastic vasculitis with IgA deposits in dermal vessels. Accordingly, IgA vasculitis (Henoch-Schönlein purpura) was diagnosed. Tocilizumab (an anti-IL-6 receptor antibody) was administered intravenously at 8 mg/kg and treatment was repeated at monthly intervals. His purpura and clinical findings specific to CD improved rapidly. CD is well known to cause various skin lesions. The findings in this case indicate that overproduction of IL-6 contributes to IgA vasculitis (Henoch-Schönlein purpura) as well as to the pathogenesis of CD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Castleman B, Towne V (1954) Case records of the massachusetts general hospital weekly clinicopathological exercises: Case 40011. N Engl J Med 250(1):26–30. doi:10.1056/nejm195401072500107
Castleman B, Iverson L, Menendez VP (1956) Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 9(4):822–830
Bonekamp D, Hruban RH, Fishman EK (2014) The great mimickers: Castleman disease. Semin Ultrasound CT MR 35(3):263–271. doi:10.1053/j.sult.2013.12.005
Dispenzieri A, Armitage JO, Loe MJ, Geyer SM, Allred J, Camoriano JK, Menke DM, Weisenburger DD, Ristow K, Dogan A, Habermann TM (2012) The clinical spectrum of castleman’s disease. Am J Hematol 87(11):997–1002. doi:10.1002/ajh.23291
Park HY, Lee JJ, Lee JB, Kim SJ, Lee SC, Won YH, Yun SJ (2011) Castleman’s disease with cutaneous involvement manifestating as multiple violaceous plaques on entire body. Ann Dermatol 23(Suppl 2):S169–S174. doi:10.5021/ad.2011.23.S2.S169
Tey HL, Tang MB (2009) A case of paraneoplastic pemphigus associated with Castleman’s disease presenting as erosive lichen planus. Clin Exp Dermatol 34(8):e754–e756. doi:10.1111/j.1365-2230.2009.03479.x
Wang L, Bu D, Yang Y, Chen X, Zhu X (2004) Castleman’s tumours and production of autoantibody in paraneoplastic pemphigus. Lancet 363(9408):525–531. doi:10.1016/s0140-6736(04)15539-6
Lopez Meiller MJ, Cavallasca JA, Maliandi Mdel R, Nasswetter GG (2008) Henoch-Schonlein purpura in adults. Clinics (Sao Paulo, Brazil) 63(2):273–276
Yang YH, Hung CF, Hsu CR, Wang LC, Chuang YH, Lin YT, Chiang BL (2005) A nationwide survey on epidemiological characteristics of childhood Henoch-Schonlein purpura in Taiwan. Rheumatology (Oxford) 44(5):618–622. doi:10.1093/rheumatology/keh544
Watts RA, Lane S, Scott DG (2005) What is known about the epidemiology of the vasculitides? Best Pract Res Clin Rheumatol 19(2):191–207. doi:10.1016/j.berh.2004.11.006
Mitsui H, Shibagaki N, Kawamura T, Matsue H, Shimada S (2009) A clinical study of Henoch-Schonlein purpura associated with malignancy. J Eur Acad Dermatol Venereol 23(4):394–401. doi:10.1111/j.1468-3083.2008.03065.x
Mayeur C, Lohmeyer LK, Leyton P, Kao SM, Pappas AE, Kolodziej SA, Spagnolli E, Yu B, Galdos RL, Yu PB, Peterson RT, Bloch DB, Bloch KD, Steinbicker AU (2014) The type I BMP receptor Alk3 is required for the induction of hepatic hepcidin gene expression by interleukin-6. Blood 123(14):2261–2268. doi:10.1182/blood-2013-02-480095
Song SN, Tomosugi N, Kawabata H, Ishikawa T, Nishikawa T, Yoshizaki K (2010) Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease. Blood 116(18):3627–3634. doi:10.1182/blood-2010-03-271791
D'Souza A, Hayman SR, Buadi F, Mauermann M, Lacy MQ, Gertz MA, Kyle RA, Kumar S, Greipp PR, Lust JA, Russell SJ, Zeldenrust S, Dingli D, Witzig TE, Rajkumar SV, Dispenzieri A (2011) The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with poems syndrome. Blood 118(17):4663–4665. doi:10.1182/blood-2011-06-362392
Uchiyama Y, Yoshida H, Koike N, Hayakawa N, Sugita A, Nishimura T, Mihara M (2008) Anti-IL-6 receptor antibody increases blood IL-6 level via the blockade of IL-6 clearance, but not via the induction of IL-6 production. Int Immunopharmacol 8(11):1595–1601. doi:10.1016/j.intimp.2008.07.002
Kimura S, Takeuchi S, Soma Y, Kawakami T (2013) Raised serum levels of interleukins 6 and 8 and antiphospholipid antibodies in an adult patient with henoch-schonlein purpura. Clin Exp Dermatol 38(7):730–736. doi:10.1111/ced.12089
Rovel-Guitera P, Diemert MC, Charuel JL, Laporte JL, Musset L, Chosidow O, Piette JC, Frances C (2000) IgA antineutrophil cytoplasmic antibodies in cutaneous vasculitis. Br J Dermatol 143(1):99–103
Ozaltin F, Bakkaloglu A, Ozen S, Topaloglu R, Kavak U, Kalyoncu M, Besbas N (2004) The significance of IgA class of antineutrophil cytoplasmic antibodies (anca) in childhood Henoch-Schonlein purpura. Clin Rheumatol 23(5):426–429. doi:10.1007/s10067-004-0910-y
Acknowledgements
This study was funded by the Okinaka Memorial Institute for Medical Research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None.
Rights and permissions
About this article
Cite this article
Oshima, Y., Hoshino, J., Suwabe, T. et al. Multicentric Castleman’s disease associated with IgA vasculitis (Henoch-Schönlein purpura) responding well to tocilizumab: a case report. Clin Rheumatol 36, 729–733 (2017). https://doi.org/10.1007/s10067-017-3568-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-017-3568-y